JP2013527854A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013527854A5 JP2013527854A5 JP2013509404A JP2013509404A JP2013527854A5 JP 2013527854 A5 JP2013527854 A5 JP 2013527854A5 JP 2013509404 A JP2013509404 A JP 2013509404A JP 2013509404 A JP2013509404 A JP 2013509404A JP 2013527854 A5 JP2013527854 A5 JP 2013527854A5
- Authority
- JP
- Japan
- Prior art keywords
- mannan
- composition
- composition according
- antigen
- oxidized
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33308610P | 2010-05-10 | 2010-05-10 | |
| AU2010901997 | 2010-05-10 | ||
| US61/333,086 | 2010-05-10 | ||
| AU2010901997A AU2010901997A0 (en) | 2010-05-10 | Immunostimulatory and vaccine compositions | |
| AU2010904060A AU2010904060A0 (en) | 2010-09-09 | Immunostimulatory and vaccine compositions | |
| AU2010904060 | 2010-09-09 | ||
| PCT/AU2011/000542 WO2011140595A2 (en) | 2010-05-10 | 2011-05-10 | Immunostimulatory and vaccine compositions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013527854A JP2013527854A (ja) | 2013-07-04 |
| JP2013527854A5 true JP2013527854A5 (https=) | 2014-06-26 |
| JP6096111B2 JP6096111B2 (ja) | 2017-03-15 |
Family
ID=44914748
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013509404A Expired - Fee Related JP6096111B2 (ja) | 2010-05-10 | 2011-05-10 | 免疫刺激組成物及びワクチン組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9597392B2 (https=) |
| EP (1) | EP2574170A4 (https=) |
| JP (1) | JP6096111B2 (https=) |
| CN (1) | CN102985095B (https=) |
| AU (1) | AU2011226992B2 (https=) |
| BR (1) | BR112012028893A2 (https=) |
| CA (1) | CA2798856C (https=) |
| RU (1) | RU2578420C2 (https=) |
| WO (1) | WO2011140595A2 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2725450T3 (es) | 2007-07-02 | 2019-09-24 | Etubics Corp | Métodos y composiciones para la producción de un vector adenoviral para su uso en vacunaciones múltiples |
| IN2014CN04251A (https=) * | 2011-11-09 | 2015-07-17 | Ascend Biopharmaceuticals Ltd | |
| WO2014031178A1 (en) | 2012-08-24 | 2014-02-27 | Etubics Corporation | Replication defective adenovirus vector in vaccination |
| ES2503516B1 (es) * | 2013-04-03 | 2015-09-09 | Inmunotek, S.L. | Complejo inmunogénico para vacunación y método de obtención |
| CA2973109A1 (en) | 2015-01-09 | 2016-07-14 | Etubics Corporation | Methods and compositions for ebola virus vaccination |
| KR102193635B1 (ko) | 2015-01-09 | 2020-12-21 | 이투빅스 코포레이션 | 복합 면역요법을 위한 방법 및 조성물 |
| WO2016172249A1 (en) * | 2015-04-20 | 2016-10-27 | Etubics Corporation | Methods and compositions for combination immunotherapy |
| JP7084881B2 (ja) | 2016-06-22 | 2022-06-15 | アルカームス インコーポレーテッド | Ｉｌ－１０の免疫刺激特性および抗炎症特性を調節するための組成物および方法 |
| FI3833378T3 (fi) | 2018-08-06 | 2025-06-16 | Nielsen Biosciences Inc | Syylien hoito |
| US11197910B1 (en) * | 2020-08-19 | 2021-12-14 | Vitruviae LLC | Fusion proteins for the diagnosis, prophylaxis and treatment of infectious diseases |
| EP4304606A4 (en) * | 2021-03-12 | 2025-08-20 | Childrens Medical Center | POLYSACCHARIDE-BASED ADJUVANTS FOR VIRUS VACCINES |
| CN113616799B (zh) * | 2021-07-13 | 2023-08-29 | 中国科学院长春应用化学研究所 | 一种疫苗载体、其制备方法及应用 |
| JPWO2024117232A1 (https=) * | 2022-11-30 | 2024-06-06 |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3362951A (en) | 1965-12-21 | 1968-01-09 | Farkas Alexander | Polysaccharide product derived from the juice of the aloe plant and methods for preparing same |
| US4735935A (en) | 1985-12-17 | 1988-04-05 | Carrington Laboratories, Inc. | Process for preparation of aloe products products, produced thereby and compositions thereof |
| US5308838A (en) | 1982-05-07 | 1994-05-03 | Carrington Laboratories, Inc. | Uses of aloe products |
| US4861761A (en) | 1984-06-28 | 1989-08-29 | Dr. Madis Laboratories, Inc. | Aloeferon isolation, manufacturing and its applications |
| FR2573656B1 (fr) * | 1984-11-29 | 1987-02-27 | Sanofi Sa | Medicament comportant en tant qu'association au moins une immunotoxine et au moins un polymere contenant du mannose |
| EP0823438A3 (en) | 1987-01-07 | 1999-09-15 | Imperial Cancer Research Technology Limited | Human mucin cone protein: peptide fragments and antibodies thereto, and uses thereof in diagnostic and therapeutic methods |
| US6222020B1 (en) | 1987-01-07 | 2001-04-24 | Imperial Cancer Research Technology Limited | Antigens derived from the core protein of the human mammary epithelial mucin |
| US5643578A (en) | 1992-03-23 | 1997-07-01 | University Of Massachusetts Medical Center | Immunization by inoculation of DNA transcription unit |
| US5744144A (en) | 1993-07-30 | 1998-04-28 | University Of Pittsburgh University Patent Committee Policy And Procedures | Synthetic multiple tandem repeat mucin and mucin-like peptides, and uses thereof |
| AUPM322393A0 (en) | 1993-12-24 | 1994-01-27 | Austin Research Institute, The | Mucin carbohydrate compounds and their use in immunotherapy |
| ATE475668T1 (de) | 1994-01-27 | 2010-08-15 | Univ Massachusetts Medical | Immunisierung durch impfung von dns transkriptionseinheit |
| US5939400A (en) | 1996-02-26 | 1999-08-17 | The Board Of Trustees Of The Leland Stanford Junior University | DNA vaccination for induction of suppressive T cell response |
| US6110898A (en) | 1996-05-24 | 2000-08-29 | University Of Maryland, Baltimore | DNA vaccines for eliciting a mucosal immune response |
| US5824659A (en) | 1996-09-04 | 1998-10-20 | Board Of Regents, The University Of Texas System | Cytoprotective oligosaccharide from Aloe preventing damage to the skin immune system by UV radiation |
| ATE341339T1 (de) | 1996-12-20 | 2006-10-15 | Merck & Co Inc | Zusammensetzungen von rekombinanten papillomavirus vakzinen |
| ES2357960T3 (es) | 1997-05-08 | 2011-05-04 | Oncothyreon Inc. | Procedimiento para generar células t activadas y células presentadoras de antígenos pulsadas con antígenos. |
| CA2329897A1 (en) | 1998-04-28 | 1999-11-04 | Galenica Pharmaceuticals, Inc. | Polysaccharide-antigen conjugates |
| IL125608A0 (en) | 1998-07-30 | 1999-03-12 | Yeda Res & Dev | Tumor associated antigen peptides and use of same as anti-tumor vaccines |
| DE19917195B4 (de) | 1999-04-16 | 2006-09-28 | Immatics Biotechnologies Gmbh | Peptid zur Auslösung einer Immunreaktion gegen Tumorzellen, diese enthaltende pharmzeutische Zusammensetzungen, dessen Verwendungen, dafür codierende Nukleinsäure und diese Nukleinsäure enthaltender Expressionsvektor |
| JP2003510094A (ja) | 1999-09-08 | 2003-03-18 | トランジェーヌ、ソシエテ、アノニム | Ｍｕｃ−１由来のペプチド |
| EP1257565A4 (en) | 2000-02-01 | 2005-04-06 | Austin Research Inst | DERIVED FROM MUCIN-1 ANTIGENE AND ITS USE IN IMMUNOTHERAPY |
| AUPQ797700A0 (en) * | 2000-06-06 | 2000-06-29 | Austin Research Institute, The | Vaccine |
| WO2008037033A1 (en) * | 2006-09-29 | 2008-04-03 | The Macfarlane Burnet Institute For Medical Research And Public Health Limited | Flu vaccine admixture of mannan and flu antigen |
| US7196072B2 (en) | 2000-07-10 | 2007-03-27 | University Of Mississippi | High molecular weight polysaccharide fraction from Aloe vera with immunostimulatory activity |
| ATE265218T1 (de) * | 2000-08-10 | 2004-05-15 | Ocean Nutrition Canada Ltd | Chlorella zubereitungen mit immunmodulatorischen eigenschaften |
| NZ538812A (en) | 2002-08-15 | 2009-02-28 | 3M Innovative Properties Co | Immunostimulatory compositions and methods of stimulating an immune response |
| AU2003256912A1 (en) | 2002-08-16 | 2004-03-03 | Yeda Research And Development Co. Ltd. | Tumor associated antigen, peptides thereof, and use of same as anti-tumor vaccines |
| WO2005044861A1 (en) | 2003-10-31 | 2005-05-19 | Wyeth Holdings Corporation | Polysaccharides of helicobacter pylori |
| EP1697515A4 (en) * | 2003-11-12 | 2008-02-06 | Austin Research Inst | DNA CARRIER CONJUGATE |
| US20060084629A1 (en) | 2004-10-15 | 2006-04-20 | Alvin Needleman | Immune system activating formula composed of selected long chain polysaccharides from natural sources |
| JP2006241023A (ja) * | 2005-03-01 | 2006-09-14 | Asahi Breweries Ltd | 消化管組織における抗菌ペプチドの発現誘導または産生促進剤 |
| JP2006241020A (ja) * | 2005-03-01 | 2006-09-14 | Asahi Breweries Ltd | 免疫系賦活剤 |
| EP1988896A4 (en) | 2006-02-22 | 2011-07-27 | 3M Innovative Properties Co | CONJUGATES TO MODIFY IMMUNE REACTIONS |
| ES2776100T3 (es) | 2006-03-31 | 2020-07-29 | Massachusetts Inst Technology | Sistema para el suministro dirigido de agentes terapéuticos |
| JP2009544291A (ja) | 2006-07-25 | 2009-12-17 | フォージー ヴァクシンズ ピーティーワイ エルーティーディー | ムチン１（ｍｕｃ１）ｔ細胞エピトープ由来ペプチド含有癌ワクチン |
| AU2007300543A1 (en) | 2006-09-26 | 2008-04-03 | Alexion Pharmaceuticals, Inc. | Compositions and methods for enhancing an adjuvant |
| US20080149123A1 (en) | 2006-12-22 | 2008-06-26 | Mckay William D | Particulate material dispensing hairbrush with combination bristles |
-
2011
- 2011-05-10 AU AU2011226992A patent/AU2011226992B2/en not_active Ceased
- 2011-05-10 US US13/696,853 patent/US9597392B2/en not_active Expired - Fee Related
- 2011-05-10 WO PCT/AU2011/000542 patent/WO2011140595A2/en not_active Ceased
- 2011-05-10 CA CA2798856A patent/CA2798856C/en not_active Expired - Fee Related
- 2011-05-10 CN CN201180033660.4A patent/CN102985095B/zh not_active Expired - Fee Related
- 2011-05-10 BR BR112012028893A patent/BR112012028893A2/pt not_active Application Discontinuation
- 2011-05-10 RU RU2012152952/15A patent/RU2578420C2/ru not_active IP Right Cessation
- 2011-05-10 JP JP2013509404A patent/JP6096111B2/ja not_active Expired - Fee Related
- 2011-05-10 EP EP11779973.4A patent/EP2574170A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013527854A5 (https=) | ||
| Stephens et al. | Considerations for a respiratory syncytial virus vaccine targeting an elderly population | |
| Rajao et al. | Swine as a model for influenza A virus infection and immunity | |
| HK1216894A1 (zh) | 多價結合蛋白組合物 | |
| JP2015171368A5 (https=) | ||
| RU2017104529A (ru) | Композиции neisseria meningitidis и способы их применения | |
| WO2016109792A3 (en) | Novel multivalent nanoparticle-based vaccines | |
| WO2012051211A3 (en) | Antigen delivery platforms | |
| WO2008021076A3 (en) | Protein matrix vaccines and methods of making and administering such vaccines | |
| CN106659777A8 (zh) | 免疫原性组合产品 | |
| JP2011529686A5 (https=) | ||
| WO2014018858A3 (en) | Multimeric fusion protein vaccine and immunotherapeutic | |
| CN110337449A (zh) | 抗pd-l1抗体及其应用 | |
| JP2011530537A5 (https=) | ||
| MX2013013111A (es) | Composicion inmunogenica que presenta antigeno multiple, y metodos y usos de la misma. | |
| CY1118080T1 (el) | Σωματιδια απελευθερωσης που ομοιαζουν με ιικα σωματιδια για αυτοαντιγραφικα rna μορια | |
| JP2014515039A5 (https=) | ||
| ATE539767T1 (de) | Adjuvans auf basis von polyinosinsäure/polycytidylsäure | |
| WO2017015463A3 (en) | Infectious disease vaccines | |
| WO2012009544A3 (en) | Domain insertion immunoglobulin | |
| WO2011039368A3 (en) | Dll4-binding molecules | |
| WO2016107818A8 (en) | Compositions and methods for protein glycosylation | |
| EP2727939A3 (en) | VEGF-binding molecules | |
| JP2015524422A5 (https=) | ||
| WO2009124309A3 (en) | Vaccines and immunotherapeutics using il-28 and compositions and methods of using the same |